ストックスクリーナーアプリを入手
18.41
3.26%
-0.62
アフターアワーズ：
18.41
前日終値:
$19.03
開ける：
$18.7
24時間の取引高:
1.76M
Relative Volume:
1.38
時価総額：
$1.06B
収益：
$2.28B
当期純損益:
$-1.13B
株価収益率:
-0.927
EPS:
-19.86
ネットキャッシュフロー:
$35.92M
1週間 パフォーマンス:
-5.10%
1か月 パフォーマンス:
-24.05%
6か月 パフォーマンス:
-22.94%
1年 パフォーマンス:
-39.56%
1日の値動き範囲:
$18.23
$18.89
1週間の範囲:
$18.23
$20.21
52週間の値動き範囲:
$18.23
$34.28
Enovis Corp Stock (ENOV) Company Profile
Compare ENOV vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
18.41 | 1.10B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-17 | 再開されました | William Blair | Outperform |
| 2026-01-06 | 開始されました | BTIG Research | Buy |
| 2024-10-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-06-13 | 開始されました | JP Morgan | Neutral |
| 2024-02-13 | 開始されました | Stephens | Overweight |
| 2024-01-22 | 開始されました | UBS | Buy |
| 2024-01-03 | 開始されました | William Blair | Outperform |
| 2023-12-15 | 繰り返されました | Needham | Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-06-26 | 開始されました | Needham | Buy |
| 2023-05-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-10-11 | 開始されました | Goldman | Buy |
| 2022-09-12 | 開始されました | Canaccord Genuity | Buy |
| 2022-09-12 | 開始されました | Evercore ISI | Outperform |
| 2022-06-28 | 開始されました | Argus | Hold |
| 2022-06-27 | 再開されました | Loop Capital | Buy |
| 2022-06-16 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Enovis Corp (ENOV) 最新ニュース
Enovis CAO Oliver Engert buys $50,008 in company stock - Investing.com
Enovis CAO Oliver Engert buys $50,008 in company stock By Investing.com - Investing.com India
Enovis CORP (ENOV) insider adds 2,660 shares in open-market buy - Stock Titan
Enovis CORP CEO McDonald Damien Acquires 13,035 Shares at $19.15 on September 4, 2026 - Kalkine Media
Enovis at Wells Fargo healthcare conference: robotics push takes center stage - Investing.com
Enovis Stock (ENOV) Opinions on eCential Robotics Acquisition - Quiver Quantitative
Enovis to acquire surgical tech provider eCential Robotics for $180M - The Robot Report
Enovis Corp (ENOV) CEO Damien Mcdonald Purchases 13,035 Shares - GuruFocus
Enovis CEO McDonald buys $249,620 in Enov shares By Investing.com - Investing.com Australia
Enovis CEO McDonald buys $249,620 in Enov shares - Investing.com
Enovis (NYSE: ENOV) CEO adds 13,035 shares in open-market buy - Stock Titan
Enovis CAO Oliver Engert buys $149,970 in company stock By Investing.com - Investing.com Canada
Enovis (NYSE: ENOV) executive buys 7,598 shares outside 10b5-1 plan - Stock Titan
Is Enovis Corp (ENOV) a Bargain After 4.3% Drop? GF Value Says U - GuruFocus
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure - Yahoo Finance
Enovis stock hits 52-week low at 19.12 USD By Investing.com - Investing.com South Africa
What Makes Enovis (ENOV) a New Buy Stock - Yahoo Finance
Enovis stock hits 52-week low at 19.12 USD - Investing.com
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Citizens JMP Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $47 - Moomoo
BMO cuts Enovis stock price target on margin headwinds from deal - Investing.com Australia
Enovis Is Maintained at Buy by Freedom Capital Markets - Moomoo
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition - Yahoo Finance
ENOV Maintained by Citizens -- Price Target Lowered to $47.00 - GuruFocus
Enovis inks eCential takeover to develop surgical ortho robots - Yahoo Finance
Enovis Is Maintained at Buy by BTIG - Moomoo
Citizens lowers Enovis stock price target on robotics acquisition - Investing.com
Citizens lowers Enovis stock price target on robotics acquisition By Investing.com - Investing.com Nigeria
BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating - Moomoo
Enovis to acquire eCential Robotics for up to €190 million By Investing.com - Investing.com Australia
Enovis to Acquire eCential Robotics for €155 Million in Surgical Robotics Deal - Minichart
Enovis to Acquire eCential Robotics for Up to €211 Million in Cash and Milestones - Kalkine Media
Enovis enters binding offer to acquire eCential Robotics By Investing.com - Investing.com Nigeria
ENOV Looks 45.5% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
ENOV Looks 45.5% Undervalued on GF Value™ - GuruFocus
ENOV Looks 45.5% Undervalued on GF Value™ Amid Strategic Acquisi - GuruFocus
Enovis to acquire eCential Robotics for €155 million - Investing.com
Enovis to Acquire eCential Robotics - marketscreener.com
Enovis to acquire eCential Robotics for €155 million By Investing.com - Investing.com Canada
Enovis to acquire eCential Robotics for up to €190 million - Investing.com
Enovis To Acquire eCential Robotics To Expand Surgical Robotics And ASTRA Enabling Technology Platform - Pulse 2.0
eCential Robotics Announces Binding Offer from Enovis - Barchart.com
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics - The Manila Times
Enovis Binding Offer: €155M Upfront Value for eCential | ENOV Stock News - Stock Titan
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference - The Manila Times
Enovis CEO and CFO will join Wells Fargo healthcare event Sept. 8 - Stock Titan
Enovis Corporation: Arvis Is Disrupting The Healthcare Industry (NYSE:ENOV) - Seeking Alpha
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man’s Land (NYSE:ENOV) - Seeking Alpha
Enovis Corp (ENOV) 財務データ
収益
当期純利益
現金流量
EPS
2.29%
0.75%
大文字化:
|
ボリューム (24 時間):